Chiao JH - Search Results

1

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.

Kelly WK, Richon VM, O'Connor O, Curley T, MacGregor-Curtelli B, Tong W, Klang M, Schwartz L, Richardson S, Rosa E, Drobnjak M, Cordon-Cordo C, Chiao JH, Rifkind R, Marks PA, Scher H. Kelly WK, et al. Among authors: chiao jh. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3578-88. Clin Cancer Res. 2003. PMID: 14506144 Clinical Trial.

2

Potential role of histone deacetylase inhibitors in mesothelioma: clinical experience with suberoylanilide hydroxamic acid.

Krug LM, Curley T, Schwartz L, Richardson S, Marks P, Chiao J, Kelly WK. Krug LM, et al. Clin Lung Cancer. 2006 Jan;7(4):257-61. doi: 10.3816/CLC.2006.n.003. Clin Lung Cancer. 2006. PMID: 16512979 Clinical Trial.

3

Histone deacetylase inhibitors: development as cancer therapy.

Marks PA, Richon VM, Kelly WK, Chiao JH, Miller T. Marks PA, et al. Among authors: chiao jh. Novartis Found Symp. 2004;259:269-81; discussion 281-8. Novartis Found Symp. 2004. PMID: 15171260

4

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer.

Kelly WK, O'Connor OA, Krug LM, Chiao JH, Heaney M, Curley T, MacGregore-Cortelli B, Tong W, Secrist JP, Schwartz L, Richardson S, Chu E, Olgac S, Marks PA, Scher H, Richon VM. Kelly WK, et al. Among authors: chiao jh. J Clin Oncol. 2005 Jun 10;23(17):3923-31. doi: 10.1200/JCO.2005.14.167. Epub 2005 May 16. J Clin Oncol. 2005. PMID: 15897550 Free PMC article. Clinical Trial.

5

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL).

Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM, Frankel SR. Duvic M, et al. Among authors: chiao jh. Blood. 2007 Jan 1;109(1):31-9. doi: 10.1182/blood-2006-06-025999. Epub 2006 Sep 7. Blood. 2007. PMID: 16960145 Free PMC article. Clinical Trial.

6

Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.

Blumenschein GR Jr, Kies MS, Papadimitrakopoulou VA, Lu C, Kumar AJ, Ricker JL, Chiao JH, Chen C, Frankel SR. Blumenschein GR Jr, et al. Among authors: chiao jh. Invest New Drugs. 2008 Feb;26(1):81-7. doi: 10.1007/s10637-007-9075-2. Epub 2007 Oct 25. Invest New Drugs. 2008. PMID: 17960324 Clinical Trial.

7

Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma.

Richardson P, Mitsiades C, Colson K, Reilly E, McBride L, Chiao J, Sun L, Ricker J, Rizvi S, Oerth C, Atkins B, Fearen I, Anderson K, Siegel D. Richardson P, et al. Leuk Lymphoma. 2008 Mar;49(3):502-7. doi: 10.1080/10428190701817258. Leuk Lymphoma. 2008. PMID: 18297527 Clinical Trial.

8

Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancer.

Hsieh WS, Soo R, Peh BK, Loh T, Dong D, Soh D, Wong LS, Green S, Chiao J, Cui CY, Lai YF, Lee SC, Mow B, Soong R, Salto-Tellez M, Goh BC. Hsieh WS, et al. Clin Cancer Res. 2009 Feb 15;15(4):1435-42. doi: 10.1158/1078-0432.CCR-08-1748. Clin Cancer Res. 2009. PMID: 19228744 Free article.

9

Phase I clinical and pharmacokinetic study of oral sapacitabine in patients with acute leukemia and myelodysplastic syndrome.

Kantarjian H, Garcia-Manero G, O'Brien S, Faderl S, Ravandi F, Westwood R, Green SR, Chiao JH, Boone PA, Cortes J, Plunkett W. Kantarjian H, et al. Among authors: chiao jh. J Clin Oncol. 2010 Jan 10;28(2):285-91. doi: 10.1200/JCO.2009.25.0209. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933907 Free PMC article. Clinical Trial.

10

Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer.

Zujewski J, Horak ID, Bol CJ, Woestenborghs R, Bowden C, End DW, Piotrovsky VK, Chiao J, Belly RT, Todd A, Kopp WC, Kohler DR, Chow C, Noone M, Hakim FT, Larkin G, Gress RE, Nussenblatt RB, Kremer AB, Cowan KH. Zujewski J, et al. J Clin Oncol. 2000 Feb;18(4):927-41. doi: 10.1200/JCO.2000.18.4.927. J Clin Oncol. 2000. PMID: 10673536 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page